Risk and Change
Workshop
W11 - Change Management and Control: Lessons From a Consent Decree
Wednesday, May 2
8:00 AM - 10:30 AM
Location: WSCC 4C 1-2
Primary Presenter(s)
-
Jeremiah Genest
MBA, CMQ/OE, CQA, MT(ASCP)
Manager, Quality Systems
Sanofi
Boston, Massachusetts
Level: Intermediate
The pharmaceutical industry is one of the most regulated industries. In the United States, the Food and Drug Administration (FDA) often uses the consent decree as the ultimate enforcement tool for those who break the rules. A company under consent decree needs to prove, via third party, that it has achieved and can sustain regulatory compliance. Companies under a consent decree must break down and build up their entire quality system. In this session, you will get lessons learned from a consent decree to build a robust pharmaceutical quality system and see how pharmaceutical experience can deepen your understanding of ISO 9001:2015, especially risk-based thinking.
Learning Objectives:
- Evaluate lessons learned from a consent decree to build a robust pharmaceutical quality system.
- Learn how the pharmaceutical experience can deepen your understanding of ISO 9001:2015, especially risk-based thinking.
- Identify how change management fits into a culture of quality.
- Understand how the change management system increases compliance.
- Use a few simple but effective tools for change management.